SYK 88.02 Stryker Corp $SYK Hit a 52 week high of 88.23 Closing the day 11/05/14 at 88.02 +0.37 +0.42% With a day low of 87.67 and a total volume of 2,155,895.
SYK Recent Posts: http://investorshangout.com/Stryker-Corp-SYK-52773/
SYK Stryker Corp Recent Headline News
Stryker to Present at Investor Conference
Thomson Reuters ONE - Wed Nov 05, 9:45AM CST
Kalamazoo, Michigan - November 5, 2014 - Stryker Corporation (NYSE:SYK) announced today that it will participate in the following investor conference:
SYK: 88.02 (+0.37)
Stryker Corporation and Subsidiary Howmedica Osteonics Jointly Announce Multi-Million-Dollar Settlement Involving Hip Implant Devices, Parker Waichman LLP Comments
PRWeb - Tue Nov 04, 4:01PM CST
Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs and medical devices notes that a settlement was just announced in the Stryker Corporation litigation involving the Rejuvenate and ABG II artificial hip implants. The multidistrict litigation (MDL) is: In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, MDL number 2441, before the U.S. Judicial Panel on Multidistrict Litigation.
SYK: 88.02 (+0.37)
Stryker (SYK) Stock Rose Today on $1.43 Billion Lawsuit Settlement
at The Street - Tue Nov 04, 3:27PM CST
Stryker (SYK) shares closed up after the company announced it was paying at least $1.43 billion to settle lawsuits against it,.
SYK: 88.02 (+0.37)
Landmark National Settlement Reached In Stryker Hip Replacement Lawsuits
PR Newswire - Tue Nov 04, 8:58AM CST
South Florida law firm Searcy Denney Scarola Barnhart & Shipley, P.A. (Searcy Denney) announced today that a national settlement has been reached on behalf of victims of the recalled Stryker Rejuvenate and ABG II hip replacement devices. It is estimated that Stryker and Howmedica Osteonics will pay well in excess of $1 billion to qualifying claimants under this settlement program.
SYK: 88.02 (+0.37)
Stryker to pay $1.43B to settle hip implant cases
AP - Mon Nov 03, 8:04PM CST
ST. PAUL, Minn. (AP) — Medical implant maker Stryker will pay at least $1.43 billion to settle thousands of lawsuits from patients who had to have surgery to remove problematic hip implants, under a deal announced Monday.
JNJ: 108.82 (+0.20), SYK: 88.02 (+0.37)
Stryker Rejuvenate and ABG II Hip Replacement Recall Settlement Summarized
Business Wire - Mon Nov 03, 5:27PM CST
Wendy Fleishman of the national plaintiffs' law firm Lieff Cabraser Heimann & Bernstein, LLP, and member of the Lead Counsel Committee, commented on the settlement announced today in the litigation against Stryker Corporation for the recall of its Rejuvenate and ABG II artificial hip implants: "Plaintiffs have a very strong case against Stryker for defective hip implants. We applaud all the parties and the Courts for encouraging an early resolution of the claims for revision surgeries."
SYK: 88.02 (+0.37)
The MDL Lead Counsel Committee: Billion Dollar+ Settlement Reached in Product Liability Case Against Stryker and Howmedica for Defective Hip Implants
Business Wire - Mon Nov 03, 4:11PM CST
--Settlement Statement Available at: https://www.stryker-mdl.com/
SYK: 88.02 (+0.37)
Meyers & Flowers Law Firm Announces Billion Dollar Settlement Reached for Patients Suffering from Stryker Corp. Medical Devices
Business Wire - Mon Nov 03, 4:08PM CST
--Settlement Statement Available at: https://www.stryker-mdl.com/
SYK: 88.02 (+0.37)
Stryker Orthopaedics Announces Settlement Agreement To Compensate Eligible U.S. Patients Who Had Surgery To Replace Their Rejuvenate Modular-Neck and/or ABG II Modular-Neck Hip Stems
Thomson Reuters ONE - Mon Nov 03, 3:25PM CST
Kalamazoo, Michigan - November 3, 2014 - Howmedica Osteonics Corp. (referred to as "Stryker Orthopaedics"
, a subsidiary of Stryker Corporation, and Court-appointed committees of attorneys representing Rejuvenate Modular-Neck and ABG II Modular-Neck plaintiffs in New Jersey Multicounty and Federal Multidistrict litigations announced a Settlement Agreement to compensate eligible U.S. patients who had surgery to replace their Rejuvenate Modular-Neck hip stem and/or ABG II Modular-Neck hip stem, known as a revision surgery, prior to November 3, 2014.
SYK: 88.02 (+0.37)
Jim Cramer's Top Stock Picks: CME AGN UNFI SYK
at The Street - Tue Oct 28, 5:00AM CDT
Cramer says Allergan doesn't need a hostile takeover to unlock shareholder value while Stryker is at the top of its game.
AGN: 196.32 (+1.20), CME: 85.77 (+0.50), UNFI: 69.07 (+0.02), SYK: 88.02 (+0.37)
Computer Assisted Surgical (CAS) Systems - 2014 Global Strategic Business Report
M2 - Tue Oct 28, 4:16AM CDT
Research and Markets (http://www.researchandmarkets.com/research/46xq77/computer_assisted) has announced the addition of the "Computer Assisted Surgical (CAS) Systems - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Computer Assisted Surgical (CAS) Systems in US$ by the following Product Segments: - Surgical Planners and Simulators - Surgical Navigation Systems - Surgical Robots The report profiles 56 companies including many key and niche players such as: - 3D Systems Corporation - Accuray, Inc. - B. Braun Melsungen AG - Brainlab AG - CAE, Inc. - CONMED Corporation - Curexo Technology Corporation - Hansen Medical, Inc. - Intuitive Surgical, Inc. - Medtronic, Inc. - Mazor Robotics Ltd. - Northern Digital Inc. - Polhemus, Inc. - Simbionix USA Corp. - Stryker Corporation Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Surgical Robots Market - A Review 3. An Insight Into Surgical Planners & Simulators Market 4. Surgical Navigation Systems Market 5. Product Overview 6. Cas In Select Medical Domains 7. Product Introductions/Innovations/ Approvals 8. Recent Industry Activity 9. Focus On Select Players 10. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Rest Of World IV. Competitive Landscape Total Companies Profiled: 56 (including Divisions/Subsidiaries - 57) - The United States (38) - Canada (3) - Japan (1) - Europe (14) - - France (1) - - Germany (6) - - The United Kingdom (2) - - Italy (1) - - Rest of Europe (4) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/46...r_assisted
ISRG: 505.37 (+9.37), MDT: 68.70 (+0.77), HNSN: 0.92 (unch), DDD: 35.77 (-2.01), CNMD: 41.67 (-0.40), MZOR: 11.16 (-0.19), ARAY: 6.88 (+0.18), SYK: 88.02 (+0.37)
Jim Cramer's 'Mad Money' Recap: How Do You Make Money in a Clueless Market?
at The Street - Mon Oct 27, 6:50PM CDT
In order to truly understand what's going on with the markets you must realize the hedge funds trump everything, Cramer says.
AGN: 196.32 (+1.20), VRX: 131.91 (-1.70), UNFI: 69.07 (+0.02), AZO: 559.15 (+4.79), CMG: 642.59 (-5.09), CFX: 54.67 (+1.17), VSLR: 14.12 (-0.84), IRBT: 34.58 (-0.71), SYK: 88.02 (+0.37)
1 Bright Spot in 3D Systems Corporation's Dismal Quarter
Todd Campbell, The Motley Fool - Motley Fool - Thu Oct 23, 9:55AM CDT
Source: 3D Systems. The promise of breakthrough technology is rarely achieved in a straight line. Demand rises and falls as markets develop, and profit surges and sags as competitors elbow one another sharply for market share. However,...
VJET: 12.89 (-1.05), DDD: 35.77 (-2.01), SSYS: 108.16 (-13.09), SYK: 88.02 (+0.37)
Recognition, Product Enhancement, Marketing Approval, Upcoming Events, and Quarterly Earnings - Research Reports on Abbott, Illumina, Thermo Fisher, Intercept and Stryker
PR Newswire - Wed Oct 22, 7:40AM CDT
Today, Analysts Review released its research reports regarding Abbott Laboratories (NYSE: ABT), Illumina Inc. (NASDAQ: ILMN), Thermo Fisher Scientific, Inc. (NYSE: TMO), Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) and Stryker Corporation (NYSE: SYK). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7389-100free.
ABT: 43.66 (+0.05), TMO: 118.55 (+0.23), ICPT: 245.94 (-14.91), ILMN: 186.37 (-5.04), SYK: 88.02 (+0.37)
United States Pressure Relief Devices Market Outlook 2020: Key Players are Hill-Rom Holdings, Inc., ArjoHuntleigh and Invacare Corp
M2 - Mon Oct 20, 8:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/26j7m3/united_states) has announced the addition of the "United States Pressure Relief Devices Market Outlook to 2020" report to their offering. "United States Pressure Relief Devices Market Outlook to 2020", provides key market data on the United States Pressure Relief Devices Therapy market. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Pressure Relief Devices market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments: - Specialty Beds Rental Business - Specialty Beds Sales Business - Mattresses (Static and Dynamic Mattresses) - Mattress Overlays (Static and Dynamic Mattress Overlays) Scope - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Pressure Relief Devices market. - Global corporate-level profiles of key companies operating within the United States Pressure Relief Devices. - Key players covered include Hill-Rom Holdings, Inc., ArjoHuntleigh and Invacare Corporation. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Pressure Relief Devices Market, United States 4 Overview of Key Companies in United States, Pressure Relief Devices Market 5 Pressure Relief Devices Market Pipeline Products 6 Recent Developments 7 Appendix Companies Mentioned - Hill-Rom Holdings, Inc. - ArjoHuntleigh - Invacare Corporation - Stryker Corporation - Linet spol s.r.o. - FXI, Inc. For more information visit http://www.researchandmarkets.com/research/26...ted_states
IVC: 15.95 (-0.10), HRC: 44.48 (+0.69), SYK: 88.02 (+0.37)
Stryker Q3 Earnings Rise, Beat by a Penny - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 17, 7:25AM CDT
Stryker's (SYK) reported net earnings for the quarter ebbed 44.7% to $57 million from $103 million in the year-ago quarter.
JNJ: 108.82 (+0.20), MDT: 68.70 (+0.77), COV: 93.32 (+1.29), SYK: 88.02 (+0.37)
Stryker (SYK) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Fri Oct 17, 2:54AM CDT
The following Stryker (SYK) conference call took place on October 16, 2014, 04:30 PM ET. This is a transcript of that earnings call:
SYK: 88.02 (+0.37)
Stryker tops Street 3Q forecasts
Automated Insights - Thu Oct 16, 3:34PM CDT
KALAMAZOO, Mich. (AP) _ Stryker Corp. (SYK) on Thursday reported net income of $57 million in its third quarter.
SYK: 88.02 (+0.37)
Stryker Reports Third Quarter 2014 Results and 2014 Outlook
Thomson Reuters ONE - Thu Oct 16, 3:00PM CDT
Kalamazoo, Michigan - October 16, 2014 - Stryker Corporation (NYSE:SYK) reported operating results for the third quarter of 2014:
SYK: 88.02 (+0.37)
Will Stryker Corp. (SYK) Disappoint This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 15, 10:20AM CDT
Our proven model does not conclusively show that Stryker Corporation (SYK) is likely to beat earnings this quarter.
EW: 121.10 (+1.32), HTWR: 77.34 (+0.20), HOLX: 26.46 (-0.58), SYK: 88.02 (+0.37)
SYK Recent Posts: http://investorshangout.com/Stryker-Corp-SYK-52773/
SYK Stryker Corp Recent Headline News
Stryker to Present at Investor Conference
Thomson Reuters ONE - Wed Nov 05, 9:45AM CST
Kalamazoo, Michigan - November 5, 2014 - Stryker Corporation (NYSE:SYK) announced today that it will participate in the following investor conference:
SYK: 88.02 (+0.37)
Stryker Corporation and Subsidiary Howmedica Osteonics Jointly Announce Multi-Million-Dollar Settlement Involving Hip Implant Devices, Parker Waichman LLP Comments
PRWeb - Tue Nov 04, 4:01PM CST
Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs and medical devices notes that a settlement was just announced in the Stryker Corporation litigation involving the Rejuvenate and ABG II artificial hip implants. The multidistrict litigation (MDL) is: In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, MDL number 2441, before the U.S. Judicial Panel on Multidistrict Litigation.
SYK: 88.02 (+0.37)
Stryker (SYK) Stock Rose Today on $1.43 Billion Lawsuit Settlement
at The Street - Tue Nov 04, 3:27PM CST
Stryker (SYK) shares closed up after the company announced it was paying at least $1.43 billion to settle lawsuits against it,.
SYK: 88.02 (+0.37)
Landmark National Settlement Reached In Stryker Hip Replacement Lawsuits
PR Newswire - Tue Nov 04, 8:58AM CST
South Florida law firm Searcy Denney Scarola Barnhart & Shipley, P.A. (Searcy Denney) announced today that a national settlement has been reached on behalf of victims of the recalled Stryker Rejuvenate and ABG II hip replacement devices. It is estimated that Stryker and Howmedica Osteonics will pay well in excess of $1 billion to qualifying claimants under this settlement program.
SYK: 88.02 (+0.37)
Stryker to pay $1.43B to settle hip implant cases
AP - Mon Nov 03, 8:04PM CST
ST. PAUL, Minn. (AP) — Medical implant maker Stryker will pay at least $1.43 billion to settle thousands of lawsuits from patients who had to have surgery to remove problematic hip implants, under a deal announced Monday.
JNJ: 108.82 (+0.20), SYK: 88.02 (+0.37)
Stryker Rejuvenate and ABG II Hip Replacement Recall Settlement Summarized
Business Wire - Mon Nov 03, 5:27PM CST
Wendy Fleishman of the national plaintiffs' law firm Lieff Cabraser Heimann & Bernstein, LLP, and member of the Lead Counsel Committee, commented on the settlement announced today in the litigation against Stryker Corporation for the recall of its Rejuvenate and ABG II artificial hip implants: "Plaintiffs have a very strong case against Stryker for defective hip implants. We applaud all the parties and the Courts for encouraging an early resolution of the claims for revision surgeries."
SYK: 88.02 (+0.37)
The MDL Lead Counsel Committee: Billion Dollar+ Settlement Reached in Product Liability Case Against Stryker and Howmedica for Defective Hip Implants
Business Wire - Mon Nov 03, 4:11PM CST
--Settlement Statement Available at: https://www.stryker-mdl.com/
SYK: 88.02 (+0.37)
Meyers & Flowers Law Firm Announces Billion Dollar Settlement Reached for Patients Suffering from Stryker Corp. Medical Devices
Business Wire - Mon Nov 03, 4:08PM CST
--Settlement Statement Available at: https://www.stryker-mdl.com/
SYK: 88.02 (+0.37)
Stryker Orthopaedics Announces Settlement Agreement To Compensate Eligible U.S. Patients Who Had Surgery To Replace Their Rejuvenate Modular-Neck and/or ABG II Modular-Neck Hip Stems
Thomson Reuters ONE - Mon Nov 03, 3:25PM CST
Kalamazoo, Michigan - November 3, 2014 - Howmedica Osteonics Corp. (referred to as "Stryker Orthopaedics"
, a subsidiary of Stryker Corporation, and Court-appointed committees of attorneys representing Rejuvenate Modular-Neck and ABG II Modular-Neck plaintiffs in New Jersey Multicounty and Federal Multidistrict litigations announced a Settlement Agreement to compensate eligible U.S. patients who had surgery to replace their Rejuvenate Modular-Neck hip stem and/or ABG II Modular-Neck hip stem, known as a revision surgery, prior to November 3, 2014. SYK: 88.02 (+0.37)
Jim Cramer's Top Stock Picks: CME AGN UNFI SYK
at The Street - Tue Oct 28, 5:00AM CDT
Cramer says Allergan doesn't need a hostile takeover to unlock shareholder value while Stryker is at the top of its game.
AGN: 196.32 (+1.20), CME: 85.77 (+0.50), UNFI: 69.07 (+0.02), SYK: 88.02 (+0.37)
Computer Assisted Surgical (CAS) Systems - 2014 Global Strategic Business Report
M2 - Tue Oct 28, 4:16AM CDT
Research and Markets (http://www.researchandmarkets.com/research/46xq77/computer_assisted) has announced the addition of the "Computer Assisted Surgical (CAS) Systems - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Computer Assisted Surgical (CAS) Systems in US$ by the following Product Segments: - Surgical Planners and Simulators - Surgical Navigation Systems - Surgical Robots The report profiles 56 companies including many key and niche players such as: - 3D Systems Corporation - Accuray, Inc. - B. Braun Melsungen AG - Brainlab AG - CAE, Inc. - CONMED Corporation - Curexo Technology Corporation - Hansen Medical, Inc. - Intuitive Surgical, Inc. - Medtronic, Inc. - Mazor Robotics Ltd. - Northern Digital Inc. - Polhemus, Inc. - Simbionix USA Corp. - Stryker Corporation Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Surgical Robots Market - A Review 3. An Insight Into Surgical Planners & Simulators Market 4. Surgical Navigation Systems Market 5. Product Overview 6. Cas In Select Medical Domains 7. Product Introductions/Innovations/ Approvals 8. Recent Industry Activity 9. Focus On Select Players 10. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Rest Of World IV. Competitive Landscape Total Companies Profiled: 56 (including Divisions/Subsidiaries - 57) - The United States (38) - Canada (3) - Japan (1) - Europe (14) - - France (1) - - Germany (6) - - The United Kingdom (2) - - Italy (1) - - Rest of Europe (4) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/46...r_assisted
ISRG: 505.37 (+9.37), MDT: 68.70 (+0.77), HNSN: 0.92 (unch), DDD: 35.77 (-2.01), CNMD: 41.67 (-0.40), MZOR: 11.16 (-0.19), ARAY: 6.88 (+0.18), SYK: 88.02 (+0.37)
Jim Cramer's 'Mad Money' Recap: How Do You Make Money in a Clueless Market?
at The Street - Mon Oct 27, 6:50PM CDT
In order to truly understand what's going on with the markets you must realize the hedge funds trump everything, Cramer says.
AGN: 196.32 (+1.20), VRX: 131.91 (-1.70), UNFI: 69.07 (+0.02), AZO: 559.15 (+4.79), CMG: 642.59 (-5.09), CFX: 54.67 (+1.17), VSLR: 14.12 (-0.84), IRBT: 34.58 (-0.71), SYK: 88.02 (+0.37)
1 Bright Spot in 3D Systems Corporation's Dismal Quarter
Todd Campbell, The Motley Fool - Motley Fool - Thu Oct 23, 9:55AM CDT
Source: 3D Systems. The promise of breakthrough technology is rarely achieved in a straight line. Demand rises and falls as markets develop, and profit surges and sags as competitors elbow one another sharply for market share. However,...
VJET: 12.89 (-1.05), DDD: 35.77 (-2.01), SSYS: 108.16 (-13.09), SYK: 88.02 (+0.37)
Recognition, Product Enhancement, Marketing Approval, Upcoming Events, and Quarterly Earnings - Research Reports on Abbott, Illumina, Thermo Fisher, Intercept and Stryker
PR Newswire - Wed Oct 22, 7:40AM CDT
Today, Analysts Review released its research reports regarding Abbott Laboratories (NYSE: ABT), Illumina Inc. (NASDAQ: ILMN), Thermo Fisher Scientific, Inc. (NYSE: TMO), Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) and Stryker Corporation (NYSE: SYK). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7389-100free.
ABT: 43.66 (+0.05), TMO: 118.55 (+0.23), ICPT: 245.94 (-14.91), ILMN: 186.37 (-5.04), SYK: 88.02 (+0.37)
United States Pressure Relief Devices Market Outlook 2020: Key Players are Hill-Rom Holdings, Inc., ArjoHuntleigh and Invacare Corp
M2 - Mon Oct 20, 8:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/26j7m3/united_states) has announced the addition of the "United States Pressure Relief Devices Market Outlook to 2020" report to their offering. "United States Pressure Relief Devices Market Outlook to 2020", provides key market data on the United States Pressure Relief Devices Therapy market. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Pressure Relief Devices market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments: - Specialty Beds Rental Business - Specialty Beds Sales Business - Mattresses (Static and Dynamic Mattresses) - Mattress Overlays (Static and Dynamic Mattress Overlays) Scope - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Pressure Relief Devices market. - Global corporate-level profiles of key companies operating within the United States Pressure Relief Devices. - Key players covered include Hill-Rom Holdings, Inc., ArjoHuntleigh and Invacare Corporation. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Pressure Relief Devices Market, United States 4 Overview of Key Companies in United States, Pressure Relief Devices Market 5 Pressure Relief Devices Market Pipeline Products 6 Recent Developments 7 Appendix Companies Mentioned - Hill-Rom Holdings, Inc. - ArjoHuntleigh - Invacare Corporation - Stryker Corporation - Linet spol s.r.o. - FXI, Inc. For more information visit http://www.researchandmarkets.com/research/26...ted_states
IVC: 15.95 (-0.10), HRC: 44.48 (+0.69), SYK: 88.02 (+0.37)
Stryker Q3 Earnings Rise, Beat by a Penny - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 17, 7:25AM CDT
Stryker's (SYK) reported net earnings for the quarter ebbed 44.7% to $57 million from $103 million in the year-ago quarter.
JNJ: 108.82 (+0.20), MDT: 68.70 (+0.77), COV: 93.32 (+1.29), SYK: 88.02 (+0.37)
Stryker (SYK) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Fri Oct 17, 2:54AM CDT
The following Stryker (SYK) conference call took place on October 16, 2014, 04:30 PM ET. This is a transcript of that earnings call:
SYK: 88.02 (+0.37)
Stryker tops Street 3Q forecasts
Automated Insights - Thu Oct 16, 3:34PM CDT
KALAMAZOO, Mich. (AP) _ Stryker Corp. (SYK) on Thursday reported net income of $57 million in its third quarter.
SYK: 88.02 (+0.37)
Stryker Reports Third Quarter 2014 Results and 2014 Outlook
Thomson Reuters ONE - Thu Oct 16, 3:00PM CDT
Kalamazoo, Michigan - October 16, 2014 - Stryker Corporation (NYSE:SYK) reported operating results for the third quarter of 2014:
SYK: 88.02 (+0.37)
Will Stryker Corp. (SYK) Disappoint This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 15, 10:20AM CDT
Our proven model does not conclusively show that Stryker Corporation (SYK) is likely to beat earnings this quarter.
EW: 121.10 (+1.32), HTWR: 77.34 (+0.20), HOLX: 26.46 (-0.58), SYK: 88.02 (+0.37)
